Brett Williams

Life Science Executive

LINKEDIN
View Profile

Brett Williams is a seasoned life science leader with global experience working at Private Equity and Venture capital-funded companies and large multinational public companies. Brett was the CEO at Verogen until the sale to Qiagen and previously was the CEO at Essen BioScience until a successful sale to Sartorius. Before these roles, he was Vice President and General Manager of Thermo Fisher Scientific’s Cellular Analysis business in the LSG group (formally Life Technologies). The core of the Cellular Analysis business is the Molecular Probes portfolio, where he led the transition from a pure reagents portfolio to a systems business with flow cytometry and imaging [microscopes and high content analysis] instrumentation as well as small benchtop cell counters and fluorimeters.